Cited by 422Metabolism, Diabetes, and CancerPeroxisome Proliferator-Activated ReceptorsNatural Antidiabetic Agents Studies

Metformin Inhibits Hepatic Gluconeogenesis Through AMP-Activated Protein Kinase–Dependent Regulation of the Orphan Nuclear Receptor SHP

Open access
Kim, Yong Deuk, Park, Keun-Gyu, Lee, Yong-Soo, Park, Yun-Yong, Kim, Don-Kyu, Nedumaran, Balachandar, Jang, Won Gu, Cho, Won-Jea +4 more·2008·Diabetes

Abstract

OBJECTIVE—Metformin is an antidiabetic drug commonly used to treat type 2 diabetes. The aim of the study was to determine whether metformin regulates hepatic gluconeogenesis through the orphan nuclear receptor small heterodimer partner (SHP; NR0B2). RESEARCH DESIGN AND METHODS—We assessed the regulation of hepatic SHP gene expression by Northern blot analysis with metformin and adenovirus containing a constitutive active form of AMP-activated protein kinase (AMPK) (Ad-AMPK) and evaluated SHP, PEPCK, and G6Pase promoter activities via transient transfection assays in hepatocytes. Knockdown of SHP using siRNA SHP was conducted to characterize the metformin-induced inhibition of hepatic gluconeogenic gene expression in hepatocytes, and metformin–and adenovirus SHP (Ad-SHP)–mediated hepatic glucose production was measured in B6-Lepob/ob mice. RESULTS—Hepatic SHP gene expression was induced by metformin, 5-aminoimidazole-4-carboxamide-1-β-d-ribofuranoside (AICAR), and Ad-AMPK. Metformin-induced SHP gene expression was abolished by adenovirus containing the dominant negative form of AMPK (Ad-DN-AMPK), as well as by compound C. Metformin inhibited hepatocyte nuclear factor-4α–or FoxA2-mediated promoter activity of PEPCK and G6Pase, and the inhibition was blocked with siRNA SHP. Additionally, SHP knockdown by adenovirus containing siRNA SHP inhibited metformin-mediated repression of cAMP/dexamethasone-induced hepatic gluconeogenic gene expression. Furthermore, oral administration of metformin increased SHP mRNA levels in B6-Lepob/ob mice. Overexpression of SHP by Ad-SHP decreased blood glucose levels and hepatic gluconeogenic gene expression in B6-Lepob/ob mice. CONCLUSIONS—We have concluded that metformin inhibits hepatic gluconeogenesis through AMPK-dependent regulation of SHP.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/db07-0381

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Metformin activates AMPK and inhibits expression of the hepatic gluconeogenic genes PEPCK and G-6-Pase similarly to insulin.

    “Metformin has been shown to activate AMPK and to inhibit the expression of the hepatic gluconeogenic genes PEPCK and G-6-Pase similarly to insulin (19).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Kim, Y. D., Park, K.-G., Lee, Y.-S., Park, Y.-Y., Kim, D.-K., Nedumaran, B., Jang, W. G., Cho, W.-J., Ha, J., Lee, I.-K., Lee, C.-H., & Choi, H.-S.
Affiliations
  • Chonnam National University (KR)
  • Keimyung University (KR)
  • Kyungpook National University (KR)
  • Kyung Hee University (KR)
  • Korea Research Institute of Bioscience and Biotechnology (KR)
Venue
Diabetes
Published
2008-02-01
Volume
57
Issue
2
Pages
306-314
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2148672071
Cited by
422
References
39
Citations by year
2026: 5 · 2025: 11 · 2024: 10 · 2023: 21 · 2022: 12 · 2021: 19 · 2020: 27 · 2019: 18 · 2018: 18 · 2017: 28 · 2016: 26 · 2015: 30 · 2014: 35 · 2013: 32 · 2012: 41
FWCI
7.28
Type
journal article
Language
en
Open access
Locations
  • Diabetes (publishedVersion)
  • PubMed (publishedVersion)
  • KRIBB Repository (submittedVersion)
  • KUMeL Repository (Keimyung University) (submittedVersion, cc-by-nc-nd)
Funders
Korea Science and Engineering Foundation
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Natural Antidiabetic Agents Studies
Keywords
metformin, hepatic gluconeogenesis, AMPK, small heterodimer partner, NR0B2, orphan nuclear receptor, phosphoenolpyruvate carboxykinase, glucose-6-phosphatase, HNF4α, FOXA2, type 2 diabetes, hepatic glucose production, ob/ob mice
MeSH terms
Animals, Gluconeogenesis, Carcinoma, Hepatocellular, Humans, Hypoglycemic Agents, Liver, Liver Neoplasms, Male, Metformin, Multienzyme Complexes, Transfection, Rats, Sprague-Dawley, Protein Serine-Threonine Kinases, Receptors, Cytoplasmic and Nuclear, Hepatocytes, RNA, Small Interfering, Cell Line, Tumor, Rats, AMP-Activated Protein Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review